Baltimore Settles with Teva, Walgreens for $160 Million in Opioid Crisis, Totaling $402.5 Million

Sep 10, 2024, 08:37 PM

The City of Baltimore has reached settlements with Teva Pharmaceuticals and Walgreens, totaling $160 million, for their roles in the city's opioid crisis. The settlement with Teva amounts to $80 million, while the settlement with Walgreens also amounts to $80 million. These settlements, announced on Monday and Tuesday, are part of a larger effort by Baltimore to address the opioid crisis, with the city securing a total of $402.5 million from various drug companies. The settlements come ahead of a trial scheduled to begin next week against the three remaining defendants in the litigation.